GE vs INBX · P/E 44, rev $13.35B vs rev $1.3M
GE Aerospace (GE) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by H. Lawrence Culp Jr..
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
GE currently screens at market cap $373.04B and trailing P/E 44.4. INBX currently screens at market cap $1.28B.
Not investment advice. Open the GE and INBX stock pages for the full models.
Not investment advice.